Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selegiline in Treatment of Cocaine Dependence
NCT00000188Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Sep 1994
- Primary completion
- Oct 1995
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of selegiline in cocaine dependence, sponsored by University of Pennsylvania. Primary endpoints: Retention, Cocaine use and 1 more. Started Sep 1994; status: completed.
02
Drugs
selegiline
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00000188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000188.